CLINICAL_TRIALS
trial_result
· 2010-12-20
Clinical Trial Update: Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits [Phase 2]
Summary
Phase 2 trial assessing armodafinil as add-on therapy for cognitive deficits in adults with schizophrenia; results on efficacy and safety were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cephalon | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2010-12-20